| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Minireviews |
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, H3T 1E2 Canada
Various mechanisms have been implicated in nitrogen mustard drug resistance. The role of these mechanisms in the development of chlorambucil drug resistance in chronic lymphocytic leukemia (CLL) is discussed. We review these mechanisms with emphasis on the emerging role of DNA repair, and specifically, recombinational repair. Inhibition of these repair processes may lead to new therapies, not only in CLL, but in other malignancies as well.
This article has been cited by other articles:
|
|
 |
|
  A. Veldurthy, M. Patz, S. Hagist, C. P. Pallasch, C.-M. Wendtner, M. Hallek, and G. Krause The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes Blood, August 15, 2008; 112(4): 1443 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamauchi, M. Ogawa, and T. Ueda Carmustine-Resistant Cancer Cells Are Sensitized to Temozolomide As A Result of Enhanced Mismatch Repair during the Development of Carmustine Resistance Mol. Pharmacol., July 1, 2008; 74(1): 82 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Amrein, M. Loignon, A.-C. Goulet, M. Dunn, B. Jean-Claude, R. Aloyz, and L. Panasci Chlorambucil Cytotoxicity in Malignant B Lymphocytes Is Synergistically Increased by 2-(Morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-Mediated Inhibition of DNA Double-Strand Break Repair via Inhibition of DNA-Dependent Protein Kinase J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 848 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. S. A. Majid, G. Smythe, W. A. Denny, and L. P. G. Wakelin Structure of the d(CGCGAATTCGCG)2 Complex of the Minor Groove Binding Alkylating Agent Alkamin Studied by Mass Spectrometry Mol. Pharmacol., April 1, 2007; 71(4): 1165 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Alzeer and O. D. Scharer A modified thymine for the synthesis of site-specific thymine-guanine DNA interstrand crosslinks Nucleic Acids Res., September 11, 2006; 34(16): 4458 - 4466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Belenkov, J.-P. Paiement, L. C. Panasci, B. P. Monia, and T. Y. K. Chow An Antisense Oligonucleotide Targeted to Human Ku86 Messenger RNA Sensitizes M059K Malignant Glioma Cells to Ionizing Radiation, Bleomycin, and Etoposide but not DNA Cross-Linking Agents Cancer Res., October 15, 2002; 62(20): 5888 - 5896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Aloyz, Z.-Y. Xu, V. Bello, J. Bergeron, F.-Y. Han, Y. Yan, A. Malapetsa, M. A. Alaoui-Jamali, A. M. V. Duncan, and L. Panasci Regulation of Cisplatin Resistance and Homologous Recombinational Repair by the TFIIH Subunit XPD Cancer Res., October 1, 2002; 62(19): 5457 - 5462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Novak, E. Oppliger Leibundgut, J. Hager, D. Muhlematter, M. Jotterand, C. Besse, N. Leupin, D. Ratschiller, J. Papp, G. Kearsey, et al. A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL) Blood, August 13, 2002; 100(5): 1787 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Spanswick, C. Craddock, M. Sekhar, P. Mahendra, P. Shankaranarayana, R. G. Hughes, D. Hochhauser, and J. A. Hartley Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma Blood, June 17, 2002; 100(1): 224 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamauchi, M. J. Keating, and W. Plunkett UCN-01 (7-Hydroxystaurosporine) Inhibits DNA Repair and Increases Cytotoxicity in Normal Lymphocytes and Chronic Lymphocytic Leukemia Lymphocytes Mol. Cancer Ther., February 1, 2002; 1(4): 287 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamauchi, B. J. Nowak, M. J. Keating, and W. Plunkett DNA Repair Initiated in Chronic Lymphocytic Leukemia Lymphocytes by 4-Hydroperoxycyclophosphamide Is Inhibited by Fludarabine and Clofarabine Clin. Cancer Res., November 1, 2001; 7(11): 3580 - 3589. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
